Zhigang Liu

机构：Dongguan People’s Hospital, Southern Medical University Shenzhen Hospital · ORCID：0000-0003-4043-3196

发表论文 124 篇 · 总被引 1856 次 · h-index 19

代表论文

• Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non–Small Cell Lung Cancer (2023 · JAMA Oncology · 被引 105)
• Machine learning powered inverse design for strain fields of hierarchical architectures (2025 · Composites Part B Engineering · 被引 23)
• Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial (2025 · Nature Communications · 被引 20)
• The novel synbiotic (Lactiplantibacillus plantarum and galacto-oligosaccharides) ameliorates obesity-related metabolic dysfunction: Arginine as a key mediator signaling molecule (2025 · Journal of Advanced Research · 被引 8)
• Direct Implantation of Patient Brain Tumor Cells into Matching Locations in Mouse Brains for Patient-Derived Orthotopic Xenograft Model Development (2024 · Cancers · 被引 8)
• Feasibility and Safety Study of Concomitant Left Bundle Branch Area Pacing and Atrioventricular Node Ablation with Same-Day Hospital Dismissal (2023 · Journal of Clinical Medicine · 被引 7)